Replacing Escherichia coli NAD-dependent glyceraldehyde 3-phosphate dehydrogenase (GAPDH) with a NADP-dependent enzyme from Clostridium acetobutylicum facilitates NADPH dependent pathways.

Reactions requiring reducing equivalents, NAD(P)H, are of enormous importance for the synthesis of industrially valuable compounds such as carotenoids, polymers, antibiotics and chiral alcohols among others. The use of whole-cell biocatalysis can reduce process cost by acting as catalyst and cofactor regenerator at the same time; however, product yields might be limited by cofactor availability within the cell. Thus, our study focussed on the genetic manipulation of a whole-cell system by modifying metabolic pathways and enzymes to improve the overall production process. In the present work, we genetically engineered an Escherichia coli strain to increase NADPH availability to improve the productivity of products that require NADPH in its biosynthesis. The approach involved an alteration of the glycolysis step where glyceraldehyde-3-phosphate (GAP) is oxidized to 1,3 bisphophoglycerate (1,3-BPG). This reaction is catalyzed by NAD-dependent endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) encoded by the gapA gene. We constructed a recombinant E. coli strain by replacing the native NAD-dependent gapA gene with a NADP-dependent GAPDH from Clostridium acetobutylicum, encoded by the gene gapC. The beauty of this approach is that the recombinant E. coli strain produces 2 mol of NADPH, instead of NADH, per mole of glucose consumed. Metabolic flux analysis showed that the flux through the pentose phosphate (PP) pathway, one of the main pathways that produce NADPH, was reduced significantly in the recombinant strain when compared to that of the parent strain. The effectiveness of the NADPH enhancing system was tested using the production of lycopene and epsilon-caprolactone as model systems using two different background strains. The recombinant strains, with increased NADPH availability, consistently showed significant higher productivity than the parent strains.

[1]  M. Penttilä,et al.  Engineering Redox Cofactor Regeneration for Improved Pentose Fermentation in Saccharomyces cerevisiae , 2003, Applied and Environmental Microbiology.

[2]  S. Agarwal,et al.  Tomato lycopene and its role in human health and chronic diseases. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  J. Keasling,et al.  Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. , 2001, Biotechnology and bioengineering.

[4]  R. Pridmore.  New and versatile cloning vectors with kanamycin-resistance marker. , 1987, Gene.

[5]  George Stephanopoulos,et al.  Modeling of Isotope Distributions and Intracellular Fluxes in Metabolic Networks Using Atom Mapping Matrices , 1994 .

[6]  M. Mihovilovic,et al.  First enantiodivergent Baeyer-Villiger oxidation by recombinant whole-cells expressing two monooxygenases from Brevibacterium. , 2003, Bioorganic & medicinal chemistry letters.

[7]  M. Reetz,et al.  Towards practical biocatalytic Baeyer-Villiger reactions: applying a thermostable enzyme in the gram-scale synthesis of optically-active lactones in a two-liquid-phase system , 2005, Beilstein journal of organic chemistry.

[8]  W. R. Farmer,et al.  Precursor Balancing for Metabolic Engineering of Lycopene Production in Escherichia coli , 2001, Biotechnology progress.

[9]  G. Bennett,et al.  Effect of different levels of NADH availability on metabolite distribution in Escherichia coli fermentation in minimal and complex media , 2004, Applied Microbiology and Biotechnology.

[10]  Robert M. Stroud,et al.  Catalytic mechanism of NADP(+)-dependent isocitrate dehydrogenase: implications from the structures of magnesium-isocitrate and NADP+ complexes. , 1991 .

[11]  Merja Penttilä,et al.  Identification of the first fungal NADP-GAPDH from Kluyveromyces lactis. , 2002, Biochemistry.

[12]  J. Stewart,et al.  A "Designer Yeast" That Catalyzes the Kinetic Resolutions of 2-Alkyl-Substituted Cyclohexanones by Enantioselective Baeyer-Villiger Oxidations. , 1996, The Journal of organic chemistry.

[13]  A. Serrano,et al.  Expression, purification, and characterization of recombinant nonphosphorylating NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Clostridium acetobutylicum. , 2002, Protein expression and purification.

[14]  Frederick C. Neidhardt,et al.  Physiology of the bacterial cell , 1990 .

[15]  P. Trudgill,et al.  The purification and properties of cyclohexanone oxygenase from Nocardia globerula CL1 and Acinetobacter NCIB 9871. , 1976, European journal of biochemistry.

[16]  M. Kula,et al.  Dehydrogenases for the synthesis of chiral compounds. , 1989, European journal of biochemistry.

[17]  G. Bennett,et al.  Effect of the global redox sensing/regulation networks on Escherichia coli and metabolic flux distribution based on C-13 labeling experiments. , 2006, Metabolic engineering.

[18]  A. Plückthun,et al.  Glycine to alanine substitutions in helices of glyceraldehyde-3-phosphate dehydrogenase: effects on stability. , 1990, Biochemistry.

[19]  T. Szyperski.  Biosynthetically Directed Fractional 13C‐labeling of Proteinogenic Amino Acids , 1995 .

[20]  K. Shimizu,et al.  Fermentation characteristics and protein expression patterns in a recombinant Escherichia coli mutant lacking phosphoglucose isomerase for poly(3-hydroxybutyrate) production , 2003, Applied Microbiology and Biotechnology.

[21]  Kazuyuki Shimizu,et al.  Gene expression patterns for metabolic pathway in pgi knockout Escherichia coli with and without phb genes based on RT-PCR. , 2003, Journal of biotechnology.

[22]  G. Bennett,et al.  Effect of Overexpression of a Soluble Pyridine Nucleotide Transhydrogenase (UdhA) on the Production of Poly(3‐hydroxybutyrate) in Escherichia coli , 2006, Biotechnology progress.

[23]  J Villadsen,et al.  Quantification of intracellular metabolic fluxes from fractional enrichment and 13C-13C coupling constraints on the isotopomer distribution in labeled biomass components. , 1999, Metabolic engineering.

[24]  J. Stewart,et al.  Understanding and Improving NADPH‐Dependent Reactions by Nongrowing Escherichia coli Cells , 2008, Biotechnology progress.

[25]  J. Villadsen,et al.  Modeling isotopomer distributions in biochemical networks using isotopomer mapping matrices. , 1997, Biotechnology and bioengineering.

[26]  P. Bowen,et al.  Role of lycopene and tomato products in prostate health. , 2005, Biochimica et biophysica acta.

[27]  M. Seeger,et al.  Cloning of Baeyer-Villiger monooxygenases from Comamonas, Xanthobacter and Rhodococcus using polymerase chain reaction with highly degenerate primers. , 2003, Environmental microbiology.

[28]  John M Woodley,et al.  On oxygen limitation in a whole cell biocatalytic Baeyer–Villiger oxidation process , 2006, Biotechnology and bioengineering.

[29]  G. Bennett,et al.  The effect of increasing NADH availability on the redistribution of metabolic fluxes in Escherichia coli chemostat cultures. , 2002, Metabolic engineering.

[30]  E. Bergner,et al.  Mass isotopomer pattern and precursor-product relationship. , 1992, Biological mass spectrometry.

[31]  P. Rouvière,et al.  Assessing the substrate selectivities and enantioselectivities of eight novel Baeyer-Villiger monooxygenases toward alkyl-substituted cyclohexanones. , 2004, The Journal of organic chemistry.

[32]  G. Phillips,et al.  High copy number plasmids compatible with commonly used cloning vectors. , 2000, BioTechniques.

[33]  W. Wiechert,et al.  Bidirectional reaction steps in metabolic networks: I. Modeling and simulation of carbon isotope labeling experiments. , 1997, Biotechnology and bioengineering.

[34]  J. Stewart,et al.  An Efficient Enzymatic Baeyer–Villiger Oxidation by Engineered Escherichiacoli Cells under Non‐Growing Conditions , 2002, Biotechnology progress.

[35]  Christoph Wittmann,et al.  Correcting mass isotopomer distributions for naturally occurring isotopes. , 2002, Biotechnology and bioengineering.

[36]  F. Neidhardt,et al.  Physiology of the bacterial cell : a molecular approach , 1990 .

[37]  M. Mihovilovic,et al.  Asymmetric oxidations at sulfur catalyzed by engineered strains that overexpress cyclohexanone monooxygenase , 1999 .

[38]  J. Nielsen,et al.  Control of fluxes towards antibiotics and the role of primary metabolism in production of antibiotics. , 2004, Advances in biochemical engineering/biotechnology.

[39]  S. Agarwal,et al.  Role of Antioxidant Lycopene in Cancer and Heart Disease , 2000, Journal of the American College of Nutrition.

[40]  K. Bose,et al.  Effect of lycopene from cooked tomatoes on serum antioxidant enzymes, lipid peroxidation rate and lipid profile in coronary heart disease. , 2007, Singapore medical journal.

[41]  Ka-Yiu San,et al.  Enhanced Lycopene Productivity by Manipulation of Carbon Flow to Isopentenyl Diphosphate in Escherichia coli , 2005, Biotechnology progress.

[42]  H. Sahm,et al.  Enantioselective reduction of carbonyl compounds by whole-cell biotransformation, combining a formate dehydrogenase and a (R)-specific alcohol dehydrogenase , 2005, Applied Microbiology and Biotechnology.

[43]  U. Bornscheuer,et al.  Cloning, expression, and characterization of a Baeyer–Villiger monooxygenase from Pseudomonas fluorescens DSM 50106 in E. coli , 2007, Applied Microbiology and Biotechnology.

[44]  P. Minorsky.  Lycopene and human health. , 2002, Plant physiology.

[45]  P. Kötter,et al.  Manipulation of malic enzyme in Saccharomyces cerevisiae for increasing NADPH production capacity aerobically in different cellular compartments. , 2004, Metabolic engineering.

[46]  G. Bennett,et al.  The effect of NAPRTase overexpression on the total levels of NAD, the NADH/NAD+ ratio, and the distribution of metabolites in Escherichia coli. , 2002, Metabolic engineering.

[47]  G. Stephanopoulos,et al.  Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. , 2005, Metabolic engineering.

[48]  D. Koshland,et al.  Determinants of performance in the isocitrate dehydrogenase of Escherichia coli , 1996, Protein science : a publication of the Protein Society.

[49]  G. Bennett,et al.  Redistribution of metabolic fluxes in Escherichia coli with fermentative lactate dehydrogenase overexpression and deletion. , 1999, Metabolic engineering.

[50]  W. Hummel.  New alcohol dehydrogenases for the synthesis of chiral compounds. , 1997, Advances in biochemical engineering/biotechnology.

[51]  G. Bennett,et al.  Novel pathway engineering design of the anaerobic central metabolic pathway in Escherichia coli to increase succinate yield and productivity. , 2005, Metabolic engineering.

[52]  W. Wiechert,et al.  Bidirectional reaction steps in metabolic networks: II. Flux estimation and statistical analysis. , 1997, Biotechnology and bioengineering.

[53]  Dae-Hee Lee,et al.  Simultaneous biocatalyst production and Baeyer-Villiger oxidation for bioconversion of cyclohexanone by recombinant Escherichia coli expressing cyclohexanone monooxygenase. , 2005, Applied biochemistry and biotechnology.

[54]  Ka-Yiu San,et al.  Metabolic engineering of Escherichia coli: increase of NADH availability by overexpressing an NAD(+)-dependent formate dehydrogenase. , 2002, Metabolic engineering.

[55]  T. Szyperski.  Biosynthetically directed fractional 13C-labeling of proteinogenic amino acids. An efficient analytical tool to investigate intermediary metabolism. , 1995, European journal of biochemistry.

[56]  K. Shimizu,et al.  Metabolic flux analysis of Escherichia coli K12 grown on 13C-labeled acetate and glucose using GC-MS and powerful flux calculation method. , 2003, Journal of biotechnology.

[57]  F X Cunningham,et al.  Molecular structure and enzymatic function of lycopene cyclase from the cyanobacterium Synechococcus sp strain PCC7942. , 1994, The Plant cell.

[58]  G. Stephanopoulos,et al.  Uncovering the gene knockout landscape for improved lycopene production in E. coli , 2008, Applied Microbiology and Biotechnology.

[59]  G. Bennett,et al.  Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. , 2002, Metabolic engineering.